Ramesh Veeragandham, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Hammond, INNPI 1710972427
Payments from drug & device makers
Across 57 payments — averaging $109.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$3K
- Artivion, Inc.$2K
- Endologix LLC$423
- Medtronic$391
- Edwards Lifesciences$163
- Johnson & Johnson$128
- plus $361 from 10 others
What the payments were for
- Travel & lodging$3,14350%
- Food & beverage$3,10050%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 17 | $2,799 |
| Artivion, Inc. | 10 | $1,979 |
| Endologix LLC | 3 | $423 |
| Medtronic(2 entities) | 7 | $391 |
| Edwards Lifesciences | 2 | $163 |
| Johnson & Johnson(2 entities) | 2 | $128 |
| Shockwave Medical, Inc | 3 | $66 |
| Abiomed | 3 | $62 |
| Angiodynamics, Inc. | 3 | $60 |
| Atricure, Inc. | 1 | $40 |
| Baxter Healthcare | 1 | $35 |
| Teleflex LLC | 1 | $34 |
| Saphena Medical, Inc. | 1 | $19 |
| Pfizer | 1 | $16 |
| Lemaitre Vascular, Inc. | 1 | $16 |
| Reflow Medical Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,244 in reported general payments places this provider in the 50th percentile of 127 thoracic surgery (cardiothoracic vascular surgery) providers in Indiana.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 65 | $661 |
| Rosuvastatin Calcium | 39 | $535 |
| Amiodarone Hcl | 30 | $446 |
| ClopidogrelClopidogrel Bisulfate | 25 | $364 |
| Mupirocin | 35 | $247 |
| Potassium Chloride | 35 | $144 |
| Famotidine | 21 | $140 |
| Losartan Potassium | 25 | $115 |
| Tamsulosin Hcl | 11 | $101 |
| Furosemide | 35 | $100 |
| Amlodipine Besylate | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Hammond
- Marc GerdischIndianapolis$2M
- David HeimansohnIndianapolis$1.5M
- Jason FrazierMunster$574K
- Sina MoainieCarmel$441K
- Vincent ScavoFort Wayne$312K
- Kenneth KeslerIndianapolis$298K
- James KellyGranger$242K
- Samuel JacobMuncie$182K
- Andrew BarksdaleIndianapolis$158K
- Joel CorveraIndianapolis$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.